Article: | MedLuna.com

Overview

Journal Acta Pharm Sin B

Publisher Elsevier

Specialty Pharmacology

Date 2024 Jan 19

PMID 38239241

Authors

Letian Song

Shenghua Gao

Bing Ye

Mianling Yang

Yusen Cheng

Dongwei Kang

Fan Yi

Jin-Peng Sun

Luis Menendez-Arias

Johan Neyts

Xinyong Liu

Peng Zhan

Affiliations

Soon will be listed here.

Citing Articles

ClickGen: Directed exploration of synthesizable chemical space via modular reactions and reinforcement learning.

Wang M, Li S, Wang J, Zhang O, Du H, Jiang D Nat Commun. 2024; 15(1):10127.

PMID: 39578485 PMC: 11584676. DOI: 10.1038/s41467-024-54456-y.

The S2 Pocket Governs the Genus-Specific Substrate Selectivity of Coronavirus 3C-Like Protease.

Zhou J, Sun P, Yang Z, Wang T, Guo J, Qiu R Adv Sci (Weinh). 2024; 11(44):e2407766.

PMID: 39377200 PMC: 11600255. DOI: 10.1002/advs.202407766.

Asymmetric imidazole-4,5-dicarboxamide derivatives as SARS-CoV-2 main protease inhibitors: design, synthesis and biological evaluation.

Huynh P, Khamplong P, Phan M, Nguyen T, Vu P, Tang Q RSC Med Chem. 2024; .

PMID: 39345712 PMC: 11423687. DOI: 10.1039/d4md00414k.

Miniaturized Modular Click Chemistry-enabled Rapid Discovery of Unique SARS-CoV-2 M Inhibitors With Robust Potency and Drug-like Profile.

Yang M, Lee M, Gao S, Song L, Jang H, Jo I Adv Sci (Weinh). 2024; 11(43):e2404884.

PMID: 39319611 PMC: 11578313. DOI: 10.1002/advs.202404884.

Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice.

Yang M, Kim M, Zhan P Acta Pharm Sin B. 2024; 14(9):4189-4192.

PMID: 39309490 PMC: 11413657. DOI: 10.1016/j.apsb.2024.07.001.

References

Hou N, Shuai L, Zhang L, Xie X, Tang K, Zhu Y . Development of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 3CLpro. ACS Cent Sci. 2023; 9(2):217-227. PMC: 9885526. DOI: 10.1021/acscentsci.2c01359. View

Sarkar A, Mandal K . Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease. Angew Chem Int Ed Engl. 2021; 60(44):23492-23494. PMC: 8652770. DOI: 10.1002/anie.202107481. View

Hao G, Wang F, Li H, Zhu X, Yang W, Huang L . Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. J Am Chem Soc. 2012; 134(27):11168-76. DOI: 10.1021/ja3001908. View

Good S, Westover J, Jung K, Zhou X, Moussa A, La Colla P . AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 and a Promising Oral Antiviral for Treatment of COVID-19. Antimicrob Agents Chemother. 2021; 65(4). PMC: 8097421. DOI: 10.1128/AAC.02479-20. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Rothan H, Teoh T . Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro). Mol Biotechnol. 2021; 63(3):240-248. PMC: 7814170. DOI: 10.1007/s12033-021-00299-7. View

de Castro S, Stevaert A, Maldonado M, Delpal A, Vandeput J, Van Loy B . A Versatile Class of 1,4,4-Trisubstituted Piperidines Block Coronavirus Replication In Vitro. Pharmaceuticals (Basel). 2022; 15(8). PMC: 9416004. DOI: 10.3390/ph15081021. View

Liang J, Wu Y, Lan K, Dong C, Wu S, Li S . Antiviral PROTACs: Opportunity borne with challenge. Cell Insight. 2023; 2(3):100092. PMC: 10308200. DOI: 10.1016/j.cellin.2023.100092. View

Hilgenfeld R . From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J. 2014; 281(18):4085-96. PMC: 7163996. DOI: 10.1111/febs.12936. View

10.

Han S, Goins C, Arya T, Shin W, Maw J, Hooper A . Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL). J Med Chem. 2021; 65(4):2880-2904. PMC: 8353992. DOI: 10.1021/acs.jmedchem.1c00598. View

11.

Rossetti G, Ossorio M, Rempel S, Kratzel A, Dionellis V, Barriot S . Non-covalent SARS-CoV-2 M inhibitors developed from in silico screen hits. Sci Rep. 2022; 12(1):2505. PMC: 8847420. DOI: 10.1038/s41598-022-06306-4. View

12.

Morris A, McCorkindale W, The Covid Moonshot Consortium , Drayman N, Chodera J, Tay S . Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed design model. Chem Commun (Camb). 2021; 57(48):5909-5912. PMC: 8204246. DOI: 10.1039/d1cc00050k. View

13.

Pillaiyar T, Flury P, Kruger N, Su H, Schakel L, Barbosa da Silva E . Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination. J Med Chem. 2022; 65(13):9376-9395. DOI: 10.1021/acs.jmedchem.2c00636. View

14.

Eloy P, Le Grand R, Malvy D, Guedj J . Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?. EBioMedicine. 2021; 74:103663. PMC: 8577853. DOI: 10.1016/j.ebiom.2021.103663. View

15.

Chen J, Wang R, Gilby N, Wei G . Omicron Variant (B.1.1.529): Infectivity, Vaccine Breakthrough, and Antibody Resistance. J Chem Inf Model. 2022; 62(2):412-422. PMC: 8751645. DOI: 10.1021/acs.jcim.1c01451. View

16.

Lyu J, Irwin J, Shoichet B . Modeling the expansion of virtual screening libraries. Nat Chem Biol. 2023; 19(6):712-718. PMC: 10243288. DOI: 10.1038/s41589-022-01234-w. View

17.

Shen Y, Altman M, Ali A, Nalam M, Cao H, Rana T . Testing the substrate-envelope hypothesis with designed pairs of compounds. ACS Chem Biol. 2013; 8(11):2433-41. PMC: 3833293. DOI: 10.1021/cb400468c. View

18.

Wang X, Huang B, Liu X, Zhan P . Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries. Drug Discov Today. 2015; 21(1):118-132. DOI: 10.1016/j.drudis.2015.08.004. View

19.

Feikin D, Higdon M, Abu-Raddad L, Andrews N, Araos R, Goldberg Y . Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022; 399(10328):924-944. PMC: 8863502. DOI: 10.1016/S0140-6736(22)00152-0. View

20.

Smith E, Davis-Gardner M, Garcia-Ordonez R, Nguyen T, Hull M, Chen E . High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2. SLAS Discov. 2020; 25(10):1152-1161. PMC: 7550789. DOI: 10.1177/2472555220963667. View